AzTrials
AzTrials

TonsillectomyHemORLNCT01904461

HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children

A study testing Vacuum device and Conventional surgery in people with Tonsillectomy and Hemorrhage, run by University Hospital, Grenoble at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The long-term objective of this study is to prove: the equivalence of the number of post-operation hemorrhages, and maybe a decrease of the number of secondary hemorrhages the decrease of pain and quicker re-feeding an easier haemostasis the simplification of the tonsillectomy surgical kit the decrease of dissection… Read more about this study

Who is it for?
Ages 3 to 10 years
What is being tested?
Vacuum device and Conventional surgery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 siteFrance
Study dates
Oct 2014to Feb 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • children from 3 to 10 years old undergoing tonsillectomy (with or without adenoidectomy)
  • children without known hemophilia or any coagulation trouble
  • children speaking and understanding French
  • children's both parents must speak and understand French
  • children's both parents must be affiliate to social security or similarly regime

Who cannot join

  • children with known allergy to silicone
  • refusal to consent: from child's age to consent or from both parents
  • telephone monitoring refusal
  • protected person referred to in Articles L1121-6 of the Code of Public Health
  • children's both parents are protected persons referred to in Articles L1121-8 of the Code of Public Health

Trial locations and contacts

1 site in 1 country.

Sébastien Schmerber, MD,PhD contact

Echipon@chu-grenoble.fr

Alexandre Moreau-Gaudry, MD, PhD contact

Echipon@chu-grenoble.fr

France1 site, 1 recruiting
  • University Hospital, Grenoble

    Grenoble, Isère, 38043

    Emilie Chipon

    Alice Hitter, MD

    Recruiting

Other trials in France

About this study

Official title: Monocentric, Prospective, Comparative and Randomised Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children

The long-term objective of this study is to prove:

  • the equivalence of the number of post-operation hemorrhages, and maybe a decrease of the number of secondary hemorrhages
  • the decrease of pain and quicker re-feeding
  • an easier haemostasis
  • the simplification of the tonsillectomy surgical kit
  • the decrease of dissection time
Being tested
Vacuum device, Conventional surgery
Keywords
tonsillectomy, children, vacuum, medical device, pain, hemorrhage, post-surgical complications
Medical subject headings
Hemorrhage, Postoperative Complications, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01904461
Study groupRoleWhat they receive
Vacuum device surgeryExperimentalAt first the surgeon proceed to the dissection of children tonsils and at last he uses the innovative vacuum device to obtain wounds hemostasis
Receives: Device: Vacuum device
Conventional surgeryActive comparatorAt first the surgeon proceed to the dissection of children tonsils and at last he uses a bipolar forceps to obtain wounds hemostasis
Receives: Procedure: Conventional surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of cauterization time to obtain the tonsillectomy wounds hemostasis using bipolar forceps between conventional surgery group and the vacuum device group

    Cauterization time (seconds) needed to obtain wounds tonsillectomy hemostasis using bipolar forceps(electric power of 20W)

    Measured: From the beginning to the end of a tonsillectomy: an expected average of 2 hours

Secondary outcomes (10)
  1. Assessment of the vacuum device hemostatic technique at his installation on the wound

    • Number of success or failure to install the device
    • Cases of no immediately hemostasis

    Measured: From the beginning to the end of a tonsillectomy: an expected average of 2 hours

  2. Assessment between two arm of the postoperative pain until 10 days after the surgery

    Pain score every day (FLACC -> children between 3 and 7 years old Faces pain scale -> children between 8 and 10 years old)

    Measured: 10 days

  3. Comparison of the time of the first complaint of pain after surgery between conventional surgery group and the vacuum device group

    Time between general anesthesia and first complaint of pain

    Measured: Time between general anesthesia and discharge hospitalization: an average of one day

  4. Comparison of surgery time between the 2 arm

    Time between the first incision and final wounds hemostasis verification

    Measured: An expected average of 2 hours

  5. Comparison between the 2 arms of re-feeding without pain (liquids,semi-liquids ands solids)

    Time or/and day of the first meal without pain

    Measured: Until 11 days after surgery

  6. Comparison between the 2 arms of the number of primary hemorrhages

    Number of primary hemorrhages

    Measured: Until 24 hours after surgery

  7. Comparison between the 2 arms of the number of secondary hemorrhages

    Number of secondary hemorrhages

    Measured: From 24 hours after surgery until 11 days after surgery

  8. Comparison between the 2 arms of the number of rehospitalisation (all circumstances)

    Number of rehospitalisation

    Measured: From 24 hours after surgery until 11 days after surgery

  9. Comparison between the 2 arms of the number of strong analgesics doses

    Number of strong analgesics doses per day. Strong analgesics are used only if the child has a FLACC score higher than 3 (children from 3 to 7 years old) and a Faces Pain Scale score higher than 4 (children from 8 to 10 years old).

    Measured: Until 11 days after surgery

  10. Clinician evaluation about the feasibility of the vacuum device installation

    Score from a qualitative satisfaction scale

    Measured: From the beginning to the end of a tonsillectomy: an expected average of 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2013 (estimated)
  2. Study startOct 2014
  3. Primary completionSep 2018 (estimated)
  4. Study completionFeb 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
74 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01904461
Sponsor's protocol ID
HemORL-DCIC-1211
Acronym
HemORL
Status last verified
Apr 2018
First submitted
5 Jul 2013
Last updated
25 Apr 2018
Results posted
No
Data monitoring committee
Yes

Publications

  • Guerrero K, Moreau-Gaudry A, Porcu P, Blin D. An innovative technique to control bleeding with vacuum device. Eur J Cardiothorac Surg. 2011 Jun;39(6):1070-2. doi: 10.1016/j.ejcts.2010.09.047. Epub 2010 Nov 12.

    PubMed 21075003
  • Brichon PY, Porcu P, Moreau-Gaudry A, Blin D. Extraction of substernal goitre using an innovative vacuum device. Eur J Cardiothorac Surg. 2012 Jul;42(1):178-9. doi: 10.1093/ejcts/ezs018. Epub 2012 Feb 13.

    PubMed 22334630
  • Porcu P, Moreau-Gaudry A, Chavanon O, Blin D. Haemostasis of a right ventricle-gunshot wound using a novel haemostatic vacuum device. Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):294-6. doi: 10.1093/icvts/ivs103. Epub 2012 May 7.

    PubMed 22566511

Questions about this trial

What is this clinical trial studying?

A study testing Vacuum device and Conventional surgery in people with Tonsillectomy and Hemorrhage, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sébastien Schmerber, MD,PhD (Echipon@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of cauterization time to obtain the tonsillectomy wounds hemostasis using bipolar forceps between conventional surgery group and the vacuum device group (time frame: From the beginning to the end of a tonsillectomy: an expected average of 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01904461, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in